Actionable news
All posts from Actionable news
Actionable news in INCY: Incyte Corporation,

Incyte (INCY) Earnings Report: Q3 2015 Conference Call Transcript


The following Incyte (INCY - Get Report) conference call took place on November 3, 2015, 10:00 AM ET. This is a transcript of that earnings call:

Company Participants

  • Michael Booth; Incyte Corporation ; Vice President IR
  • Herve Hoppenot; Incyte Corporation ; President & CEO
  • Barry Flannery; Incyte Corporation ; EVP & General Manager US
  • Richard Levy; Incyte Corporation ; EVP Chief Drug Development Officer
  • David Gryska; Incyte Corporation ; CFO
  • Reid Huber; Incyte Corporation ; EVP & Chief Scientific Officer

Other Participants

  • Carter Gould; Barclays ; Analyst
  • Matthew Roden; UBS ; Analyst
  • Marc Frahm; Cowen and Company ; Analyst
  • Brittany Turner; JPMorgan ; Analyst
  • Maury Raycroft; Jefferies & Co. ; Analyst
  • Christopher Marai; Oppenheimer & Co. ; Analyst
  • Michael Schmidt; Leerink Partners ; Analyst
  • Unidentified Participant; Bank of America ; Analyst
  • Liisa Bayko; JMP Securities ; Analyst
  • Tony Butler; Guggenheim Securities ; Analyst

MANAGEMENT DISCUSSION SECTION Operator: Welcome to the Incyte third quarter 2015 financial results.


(Operator Instructions) As a reminder this conference is being recorded. I would now like to turn the conference over to your host, Mr. Michael Booth, Vice President of Investor Relations for Incyte . Please go ahead. Michael Booth (Vice President IR): Thank you. Good morning. Welcome to Incyte's third quarter 2015 earnings conference call and webcast. The slides used today will be made available for download on the Investor Section of following the call. Speaking on the call will...